Prof. Rajshekhar Karpoormath K. is a full professor in the Department of Pharmaceutical Chemistry at the College of Health Sciences, University of KwaZulu-Natal (UKZN) in Durban, South Africa. He heads the Synthetic and Medicinal Chemistry Research Group (SMCRG), with a primary focus on anti-TB drug discovery. He has obtained numerous institutional, national, and international grants throughout his career, establishing a state-of-the-art drug discovery laboratory. He collaborates actively with international institutions, fostering innovation in medicinal chemistry and drug discovery. His contributions were recognized when he received a prestigious grant from the Bill and Melinda Gates Foundation, serving as Co-PI in 2023 and PI in 2024, to enhance anti-TB drug development efforts. His main research focus areas are: target-based drug design and synthesis of small molecules as potential anticancer and antimicrobial agents, and Methodology development and the development of electroanalytical methods to trace biological and organic species by fabricating or modifying electrodes with nanomaterials.